Cause of death, by non-communicable diseases, male in East Asia & Pacific (IDA & IBRD countries)
East Asia & Pacific (IDA & IBRD countries): Cause of death, by non-communicable diseases, male was 79.2% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, male in East Asia & Pacific (IDA & IBRD countries), 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths.
Analysis
East Asia & Pacific (IDA & IBRD countries) recorded 79.2% for cause of death, by non-communicable diseases, male in 2021.
That represents a change of down 4.0% on the previous year and down 1.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, male in East Asia & Pacific (IDA & IBRD countries) peaked at 84.5% in 2019 and was at its lowest, 72.7%, in 2000.
That places East Asia & Pacific (IDA & IBRD countries) 3rd out of 47 groups with data for 2021, putting it in the top 10%.
Cause of death, by non-communicable diseases, male in East Asia & Pacific (IDA & IBRD countries), year by year
| Year | % of total male deaths | Change |
|---|---|---|
| 2000 | 72.7% | — |
| 2010 | 80.2% | +10.3% |
| 2015 | 82.7% | +3.1% |
| 2019 | 84.5% | +2.1% |
| 2020 | 82.5% | -2.4% |
| 2021 | 79.2% | -4.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 72.7% | 72.7% | 72.7% | 1 |
| 2010s | 82.5% | 80.2% | 84.5% | 3 |
| 2020s | 80.8% | 79.2% | 82.5% | 2 |
Countries ranked near East Asia & Pacific (IDA & IBRD countries)
More health data for East Asia & Pacific (IDA & IBRD countries)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate -0.843 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0369 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, annual growth rate -4.17 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 2.03 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0353 units per person (2025)
- Population ages 35-39, female, per capita 0.0397 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, male in East Asia & Pacific (IDA & IBRD countries)?
- Cause of death, by non-communicable diseases, male in East Asia & Pacific (IDA & IBRD countries) was 79.2% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, male recorded in East Asia & Pacific (IDA & IBRD countries)?
- The highest recorded value was 84.5% in 2019.
- What is the lowest cause of death, by non-communicable diseases, male recorded in East Asia & Pacific (IDA & IBRD countries)?
- The lowest recorded value was 72.7% in 2000.
- How does East Asia & Pacific (IDA & IBRD countries) rank for cause of death, by non-communicable diseases, male?
- East Asia & Pacific (IDA & IBRD countries) ranks 3rd out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, male rising or falling in East Asia & Pacific (IDA & IBRD countries)?
- Over the last ten years it is down 1.3%. The long-run trend across the full record is rising.
- Where does this East Asia & Pacific (IDA & IBRD countries) data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.